Marco Borgogno

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Autism Spectrum Disorder

Reactive Oxygen Species

Top Venues

ACS pharmacology & translational science

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Annalisa Savardi, Andrea Patricelli Malizia, Marco De Vivo, Laura Cancedda, Marco Borgogno
Preclinical Development of the Na-K-2Cl Co-transporter-1 (NKCC1) Inhibitor ARN23746 for the Treatment of Neurodevelopmental Disorders. ACS pharmacology & translational science 6 (1) (2023)
Annalisa Savardi, Andrea Patricelli Malizia, Marco De Vivo, Laura Cancedda, Marco Borgogno
Preclinical Development of the Na-K-2Cl Co-transporter-1 (NKCC1) Inhibitor ARN23746 for the Treatment of Neurodevelopmental Disorders. ACS pharmacology & translational science 6 (1) (2023)
Marco Borgogno, Annalisa Savardi, Jacopo Manigrasso, Alessandra Turci, Corinne Portioli, Giuliana Ottonello, Sine Mandrup Bertozzi, Andrea Armirotti, Andrea Contestabile, Laura Cancedda, Marco De Vivo
Design, Synthesis, In Vitro and In Vivo Characterization of Selective NKCC1 Inhibitors for the Treatment of Core Symptoms in Down Syndrome. Journal of medicinal chemistry 64 (14) (2021)